Abstract
The structures of caspases reveal the mechanism of binding for non-peptide and protein inhibitors, and have been applied in the design of agents that either inhibit or activate caspases to control cell death in diverse diseases. Decreased cell death is desirable for treatment of stroke, nerve crush injury, myocardial infarction, neuromuscular and neurodegenerative diseases and several non-peptide caspase inhibitors have been developed. In contrast, activation of cell death would be advantageous in cancer therapy, and the strategy is to block the binding of inhibitory proteins to caspases. Recent preclinical studies are described.
Keywords: Cysteine protease, drug design, cell death, substrate recognition, apoptosis
Mini-Reviews in Medicinal Chemistry
Title: Caspases: Structure-Guided Design of Drugs to Control Cell Death
Volume: 8 Issue: 11
Author(s): Irene T. Weber, Bin Fang and Johnson Agniswamy
Affiliation:
Keywords: Cysteine protease, drug design, cell death, substrate recognition, apoptosis
Abstract: The structures of caspases reveal the mechanism of binding for non-peptide and protein inhibitors, and have been applied in the design of agents that either inhibit or activate caspases to control cell death in diverse diseases. Decreased cell death is desirable for treatment of stroke, nerve crush injury, myocardial infarction, neuromuscular and neurodegenerative diseases and several non-peptide caspase inhibitors have been developed. In contrast, activation of cell death would be advantageous in cancer therapy, and the strategy is to block the binding of inhibitory proteins to caspases. Recent preclinical studies are described.
Export Options
About this article
Cite this article as:
Weber T. Irene, Fang Bin and Agniswamy Johnson, Caspases: Structure-Guided Design of Drugs to Control Cell Death, Mini-Reviews in Medicinal Chemistry 2008; 8 (11) . https://dx.doi.org/10.2174/138955708785909899
DOI https://dx.doi.org/10.2174/138955708785909899 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Role of Descending Aminergic Pathways in the Development of Locomotion
Current Pharmaceutical Design Neurovascular Signals Suggest a Propagation Mechanism for Endogenous Stem Cell Activation Along Blood Vessels
CNS & Neurological Disorders - Drug Targets Role of Neurotrophins in Spinal Plasticity and Locomotion
Current Pharmaceutical Design How Does the Treadmill Affect Gait in Parkinsons Disease?
Current Aging Science The Panomics Approach in Neurodegenerative Disorders
Current Medicinal Chemistry Blockers of Voltage-Gated Sodium Channels for the Treatment of Central Nervous System Diseases
Recent Patents on CNS Drug Discovery (Discontinued) The Modulation of Pain by Metabotropic Glutamate Receptors 7 and 8 in the Dorsal Striatum
Current Neuropharmacology Stem Cells Therapies in Basic Science and Translational Medicine: Current Status and Treatment Monitoring Strategies
Current Pharmaceutical Biotechnology Autoimmune (Auto-inflammatory) Syndrome Induced by Adjuvants (ASIA) – Animal Models as a Proof of Concept
Current Medicinal Chemistry The Clinical Difference between Gabapentin and Pregabalin: Data from a Pilot Comparative Trial
Reviews on Recent Clinical Trials Recent Patents on Drugs Addressing Neurodegenerative Diseases
Recent Patents on Biomarkers Apoptosis: A Key in Neurodegenerative Disorders
Current Neurovascular Research Neuropeptides as Possible Targets in Sleep Disorders: Special Emphasis on Hypocretin-Deficient Narcolepsy
CNS & Neurological Disorders - Drug Targets Patent Selections
Recent Patents on CNS Drug Discovery (Discontinued) COX-2 and mPGES in Brain Endothelial Cells: Potential Targets of Anti- Inflammatory Drugs
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Sub-Cellular Distribution and Translocation of TRP Channels
Current Pharmaceutical Biotechnology Neurotrophic Factors for Retinal Ganglion Cell Neuropathy - With a Special Reference to Diabetic Neuropathy in the Retina
Current Diabetes Reviews Intravesical Botox for Overactive Bladder: How to Minimize Complications and Manage Failures
Current Drug Targets Functional Genomics: New Insights into the Function of Low Levels of Gene Expression in Stem Cells
Current Genomics Substance P and Alzheimer’s Disease: Emerging Novel Roles
Current Alzheimer Research